Shareholders of the largest pharmaceutical company in Nigeria, Fidson Healthcare Plc, have approved a dividend of ₦1.50 per 50 kobo ordinary share, amounting to ₦3.6 billion.
The company explained that the approved N3.6bn dividend reflects shareholders’ confidence in the company’s ability to deliver sustainable value despite a challenging operating environment.
The approval was made at the company’s 27th Annual General Meeting held virtually on July 30, 2026.
Aside from approving the dividend, the election and re-election of directors, authorisation to fix auditors’ remuneration, and the election of members of the Statutory Audit Committee were other resolutions that shareholders considered and approved at the AGM.
In his address to shareholders, the Founder and Chairman of Fidson Healthcare Plc, Dr. Fidelis Ayebae, said 2025 marked a defining year in the company’s history.
According to him, Fidson became the first pharma company in Nigeria to surpass N100 billion annual revenue.
“We recorded revenue of
...
This post was originally published on this site.
